Vagotomy and subsequent risk of P arkinson's disease

E Svensson, E HorváthPuhó, RW Thomsen… - Annals of …, 2015 - Wiley Online Library
Objective Parkinson's disease (PD) may be caused by an enteric neurotropic pathogen
entering the brain through the vagal nerve, a process that may take over 20 years. We …

Multisystem morbidity and mortality in Cushing's syndrome: a cohort study

OM Dekkers, E Horváth-Puhó… - The Journal of …, 2013 - academic.oup.com
Context: Cushing's syndrome (CS) is associated with hypercoagulability, insulin resistance,
hypertension, bone loss, and immunosuppression. To date, no adequately large cohort …

Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study

KK Søgaard, E Horváth-Puhó, H Grønbæk… - Official journal of the …, 2009 - journals.lww.com
Erzsébet Horváth-Puhó contributed to the design of the study and to the analysis and
interpretation of the data. Peter Jepsen participated in the analysis and interpretation of data, and …

Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study

SA Johannesdottir, E Horváth-Puhó… - JAMA internal …, 2013 - jamanetwork.com
Importance Excess endogenous cortisol has been linked to venous thromboembolism (VTE)
risk, but whether this relationship applies to exogenous glucocorticoids remains uncertain. …

Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting

…, J Acuña, P Velebil, J Jirova, E Horváth-Puhó… - The Lancet, 2023 - thelancet.com
Small newborns are vulnerable to mortality and lifelong loss of human capital. Measures of
vulnerability previously focused on liveborn low-birthweight (LBW) babies, yet LBW reduction …

Existing data sources for clinical epidemiology: the Danish National Database of Reimbursed Prescriptions

SA Johannesdottir, E Horváth-Puhó… - Clinical …, 2012 - Taylor & Francis
The Danish health care system provides partial reimbursement of most prescription medications
in Denmark. The dispensation of prescription medications is registered in administrative …

[HTML][HTML] Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?

SD Østergaard, M Schmidt, E Horváth-Puhó… - The Lancet, 2021 - thelancet.com
By mid March, 2021, vaccination against COVID-19 using the ChAdOx1 nCoV-19 (AZD1222)
vaccine from Oxford–AstraZeneca1, 2 was paused in a number of European countries due …

30-year mortality after venous thromboembolism: a population-based cohort study

KK Søgaard, M Schmidt, L Pedersen, E HorváthPuhó… - Circulation, 2014 - Am Heart Assoc
Background— Studies on long-term mortality after venous thromboembolism (VTE) are
sparse. Methods and Results— Using Danish medical databases, we conducted a 30-year …

Venous thromboembolism in cancer patients: a population-based cohort study

FI Mulder, E Horvàth-Puhó, N van Es… - Blood, The Journal …, 2021 - ashpublications.org
The incidence of venous thromboembolism (VTE) in cancer patients may have changed in
the past decade, possibly due to novel cancer therapies, improved survival, and high-…

Migraine and risk of cardiovascular diseases: Danish population based matched cohort study

…, L Holland-Bill, V Ehrenstein, E Horváth-Puhó… - Bmj, 2018 - bmj.com
Objective To examine the risks of myocardial infarction, stroke (ischaemic and haemorrhagic),
peripheral artery disease, venous thromboembolism, atrial fibrillation or atrial flutter, and …